comparemela.com

Lotan Helfman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CMS Promotes Competition, Transparency, Health Equity and More in the CY2025 Medicare Advantage and Part D Proposed Rule | Sheppard Mullin Richter & Hampton LLP

Drug Manufacturer Merck Fights Medicare Price Negotiations

Drug manufacturer Merck and four chambers of commerce are suing to stop implementation of the Inflation Reduction Act's Medicare and Medicaid prescription drug cost negotiation plan. Merck argues the law is unconstitutional because it interferes with the free market economy.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.